Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Francisco J. de Abajo, Sara Rodríguez‐Martín, Victoria Lerma, Gina Mejía‐Abril, Mónica Aguilar, Amelia García-Luque, Leonor Laredo, Olga Laosa, Gustavo Adolfo Centeno-Soto, María A. Gálvez, Miguel Puerro, Esperanza González‐Rojano, Laura Pedraza, Itziar de Pablo, Francisco Abad‐Santos, Leocadio Rodríguez‐Mañas, Miguel Gil, Aurelio Tobı́as, Antonio Rodríguez, Diego Rodrı́guez-Puyol, Diana Barreira‐Hernández, Pablo Zubiaur, Elena Santos-Molina, Elena Pintos-Sánchez, Marcos Navares‐Gómez, Rubén Aparicio, V. García-Rosado, Carlos Gutiérrez-Ortega, Carlos A. Perez, Ana Ascaso, C Elvira
Topics & Concepts
MedicineEpidemiologyOdds ratioPopulationConfoundingPediatricsLogistic regressionInternal medicineEmergency medicineEnvironmental healthCOVID-19 Clinical Research StudiesRenin-Angiotensin System StudiesLong-Term Effects of COVID-19